Subscribe To
Dbv technologies to present new data at acaai 2023
Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12...
November 2, 2023, 4:30 pm
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...
November 2, 2023, 9:17 am
Kalvista pharmaceuticals to present data at the 2023 annual scientific meeting of the american college of allergy, asthma & immunology
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
November 2, 2023, 6:30 am
Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting
SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, dev...
October 31, 2023, 9:05 am
Acceptance of polyamine inhibitor car-t combination abstract for online publication
MINNEAPOLIS, Oct. 25, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics...
October 25, 2023, 12:15 pm
Carisma to present first results from in vivo car-m collaboration with moderna at sitc 2023
-Late-breaking abstract to be presented on November 3 rd at 11:30 am PT highlighting pre-clinical data with Moderna -Two additional pre-clinical data ...
October 25, 2023, 9:11 am
Aclarion announces nociscan® cost-effectiveness poster presented at 45th annual smdm meeting
Nociscan cost-effectiveness abstract poster highlights dominance over provocative discography. The 45th Annual Society for Medical Decision Making (SM...
October 24, 2023, 12:45 pm
Calliditas therapeutics to present seven abstracts at the american society of nephrology (asn) kidney week 2023
STOCKHOLM , Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced seven ab...
October 19, 2023, 3:58 am
Astrazeneca shares fall as abstract for lung cancer trial data disappoints
Shares in AstraZeneca fell more than 4% on Wednesday after the publication of an abstract on its experimental precision drug's use in lung cancer in a...
October 18, 2023, 8:26 am
Apollomics announces presentations of vebreltinib data at esmo 2023
FOSTER CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (the “Company”), a late-stage clinical biopharmaceutical co...
October 16, 2023, 10:55 pm
Guaranty bancshares, inc. (gnty) q3 2023 earnings call transcript
Guaranty Bancshares, Inc. (NYSE:GNTY ) Q3 2023 Earnings Conference Call October 16, 2023 11:00 AM ET Company Participants Ty Abston - Chairman and Chi...
October 16, 2023, 12:48 pm
Volitionrx to present cancer detection abstracts at european oncology conference
VolitionRx (NYSE-A:VNRX) said it will be presenting three scientific abstracts about cancer detection tools at the annual congress of the European Soc...
October 16, 2023, 10:11 am
Merck to present latest research from oncology portfolio at esmo 2023
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research ...
October 16, 2023, 2:00 am
Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsenta...
October 13, 2023, 8:30 pm
Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI ® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsent...
October 13, 2023, 4:30 pm
Pharvaris to present at the apaaaci 2023 international conference
ZUG, Switzerland, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor a...
October 13, 2023, 6:50 am
Arbutus announces multiple abstracts accepted for presentation at aasld – the liver meeting® 2023
Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Na...
October 11, 2023, 12:05 pm
Vir biotechnology announces multiple abstracts highlighting new chronic hepatitis b and hepatitis delta data accepted for presentation at aasld’s the liver meeting® 2023
SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that eight abstracts highlighting new data fro...
October 11, 2023, 12:00 pm
Bioatla provides guidance on near-term milestones and plans to announce third quarter 2023 financial results and business update on november 7, 2023
Submitted abstract on CAB-AXL-ADC, BA3011, in non-small cell lung cancer (NSCLC) to the IASLC 2023 North America Conference on Lung Cancer; KOL event ...
October 10, 2023, 11:30 am
Koru medical systems to present two abstracts at the immunoglobulin national society 2023 national conference
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focus...
October 5, 2023, 7:05 am